251 related articles for article (PubMed ID: 9283213)
81. Relationships of oxidized HDL with blood coagulation and fibrinolysis in patients with type 2 diabetes mellitus.
Ebara S; Marumo M; Mukai J; Ohki M; Uchida K; Wakabayashi I
J Thromb Thrombolysis; 2018 Feb; 45(2):200-205. PubMed ID: 29247447
[TBL] [Abstract][Full Text] [Related]
82. Significance of glomerular deposition of apolipoprotein (a) in various glomerulopathies.
Suzuki S; Takahashi H; Sato H; Takashima N; Arakawa M; Gejyo F
Am J Nephrol; 1997; 17(6):499-504. PubMed ID: 9426845
[TBL] [Abstract][Full Text] [Related]
83. Activation of the fibrinolytic, coagulation and plasma kallikrein-kinin systems during and after open heart surgery in children.
Saatvedt K; Lindberg H; Michelsen S; Pedersen T; Geiran OR
Scand J Clin Lab Invest; 1995 Jul; 55(4):359-67. PubMed ID: 7569739
[TBL] [Abstract][Full Text] [Related]
84. [Significance of urinary fibrin/fibrinogen degradation product (FDP) D-dimer measured by highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases].
Shibata T; Magari Y; Mizunaga S; Okabe E; Sumie A; Ishii T; Tomo T; Yasumori R; Nasu M
Nihon Jinzo Gakkai Shi; 1994 Jul; 36(7):805-12. PubMed ID: 8072218
[TBL] [Abstract][Full Text] [Related]
85. Effects of a protease inhibitor, ulinastatin, on coagulation and fibrinolysis in abdominal surgery.
Nishiyama T; Yokoyama T; Yamashita K
J Anesth; 2006; 20(3):179-82. PubMed ID: 16897236
[TBL] [Abstract][Full Text] [Related]
86. Significance of elevated thrombin-antithrombin III complex and plasmin-alpha 2-plasmin inhibitor complex in the acute stage of nontraumatic subarachnoid hemorrhage.
Itoyama Y; Fujioka S; Takaki S; Morioka M; Hide T; Ushio Y
Neurosurgery; 1994 Dec; 35(6):1055-60. PubMed ID: 7533897
[TBL] [Abstract][Full Text] [Related]
87. Hemostasis activation in patients with liver cirrhosis.
Vukovich T; Teufelsbauer H; Fritzer M; Kreuzer S; Knoflach P
Thromb Res; 1995 Feb; 77(3):271-8. PubMed ID: 7740519
[TBL] [Abstract][Full Text] [Related]
88. [A case of medically treated type A acute aortic dissection: trial of antifibrinolytic therapy while monitoring the thrombotic and fibrinolytic parameters].
Tsushima Y; Hata T; Namba H; Sone Y; Tezuka M; Shinozaki M; Murakami T; Hamanaka S; Taniguchi G
Kokyu To Junkan; 1992 Jul; 40(7):695-8. PubMed ID: 1381516
[TBL] [Abstract][Full Text] [Related]
89. Fibrinolysis in patients with diabetic nephropathy determined by plasmin-alpha 2 plasmin inhibitor complexes in plasma.
Yagame M; Eguchi K; Suzuki D; Machimura H; Takeda H; Inoue W; Tanaka K; Kaneshige H; Nomoto Y; Sakai H
J Diabet Complications; 1990; 4(4):175-8. PubMed ID: 2151230
[TBL] [Abstract][Full Text] [Related]
90. Plasma lipoprotein (a) levels and fibrinolytic activity in acute myocardial infarction.
Honda Y; Oshima S; Ogawa H; Sakamoto T; Miyao Y; Sakata S; Hirashima O; Moriyama Y; Yasue H
Jpn Circ J; 1994 Dec; 58(12):869-76. PubMed ID: 7699733
[TBL] [Abstract][Full Text] [Related]
91. Recombinant hirudin for the treatment of disseminated intravascular coagulation in patients with haematological malignancy.
Saito M; Asakura H; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Matsuda T
Blood Coagul Fibrinolysis; 1995 Feb; 6(1):60-4. PubMed ID: 7540878
[TBL] [Abstract][Full Text] [Related]
92. Activation of intravascular coagulation in Bell's palsy.
Omori H; Ikeda M; Kukimoto N; Kawamoto H; Ikui A; Tomita H
Eur Arch Otorhinolaryngol; 1994 Dec; ():S471-2. PubMed ID: 10774425
[No Abstract] [Full Text] [Related]
93. Increased tissue factor pathway inhibitor in patients with acute myocardial infarction.
Kamikura Y; Wada H; Yamada A; Shimura M; Hiyoyama K; Shiku H; Tanigawa M; Nishikawa H; Yamada N; Isaka N; Nakano T; Kumeda K; Kato H
Am J Hematol; 1997 Aug; 55(4):183-7. PubMed ID: 9257877
[TBL] [Abstract][Full Text] [Related]
94. Status of the coagulation and fibrinolytic systems in ovarian hyperstimulation syndrome.
Kodama H; Fukuda J; Karube H; Matsui T; Shimizu Y; Tanaka T
Fertil Steril; 1996 Sep; 66(3):417-24. PubMed ID: 8751741
[TBL] [Abstract][Full Text] [Related]
95. Plasmin and thrombin inhibitors in essentially untreated patients with coronary artery spasm.
Handa K; Kimoto K; Kawaguchi H; Mori T; Matsunaga A; Sasaki J; Arakawa K
Int J Cardiol; 1993 Dec; 42(3):263-7. PubMed ID: 7511130
[TBL] [Abstract][Full Text] [Related]
96. Development of a chemiluminescence assay for tissue plasminogen activator inhibitor complex and its applicability to gastric cancer.
Ji Y; Qin Y; Tan Q; Qiu Y; Han S; Qi X
BMC Biotechnol; 2024 May; 24(1):30. PubMed ID: 38720310
[TBL] [Abstract][Full Text] [Related]
97. Hemostatic abnormalities in patients with thrombotic complications on maintenance hemodialysis.
Inoue A; Wada H; Takagi M; Yamamuro M; Mukai K; Nakasaki T; Shimura M; Hiyoyama K; Deguchi H; Gabazza EC; Mori Y; Nishikawa M; Deguchi K; Shiku H
Clin Appl Thromb Hemost; 2000 Apr; 6(2):100-3. PubMed ID: 10775031
[TBL] [Abstract][Full Text] [Related]
98. Circadian variations of plasma levels of blood coagulation/fibrinolysis molecular markers in progressive systemic sclerosis (PSS).
Maeda M; Kachi H; Kitajima Y
J Dermatol Sci; 1996 Oct; 13(1):18-24. PubMed ID: 8902649
[TBL] [Abstract][Full Text] [Related]
99. Plasma coagulation profiles in patients with severe primary pulmonary hypertension.
Hoeper MM; Sosada M; Fabel H
Eur Respir J; 1998 Dec; 12(6):1446-9. PubMed ID: 9877507
[TBL] [Abstract][Full Text] [Related]
100. Fibrinolytic parameters as an admission prognostic marker of head injury in patients who talk and deteriorate.
Takahashi H; Urano T; Takada Y; Nagai N; Takada A
J Neurosurg; 1997 May; 86(5):768-72. PubMed ID: 9126890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
